TWi Biotechnology, Inc. (TPEX:6610)
30.95
-2.55 (-7.61%)
Sep 19, 2025, 2:59 PM CST
TWi Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 332.56 | 126.8 | 151.83 | 160.4 | 188.84 | 64.12 | Upgrade |
Short-Term Investments | - | 16 | 171.85 | - | 34.3 | 148.2 | Upgrade |
Cash & Short-Term Investments | 332.56 | 142.8 | 323.69 | 160.4 | 223.14 | 212.32 | Upgrade |
Cash Growth | 44.33% | -55.88% | 101.80% | -28.12% | 5.10% | -45.05% | Upgrade |
Other Receivables | 0.93 | 0.89 | 0.44 | 0.57 | 4.13 | 0.72 | Upgrade |
Receivables | 0.93 | 0.89 | 0.44 | 0.57 | 4.13 | 0.72 | Upgrade |
Inventory | - | - | - | - | - | 2.34 | Upgrade |
Prepaid Expenses | 1.21 | - | - | 1 | 1.41 | 1.27 | Upgrade |
Other Current Assets | - | 34.36 | 0.8 | - | - | - | Upgrade |
Total Current Assets | 334.7 | 178.05 | 324.93 | 161.97 | 228.68 | 216.65 | Upgrade |
Property, Plant & Equipment | 4.89 | 6.56 | 9.96 | 5.75 | 9.54 | 13.68 | Upgrade |
Long-Term Investments | - | - | - | 1 | 1 | 79 | Upgrade |
Other Intangible Assets | 30.25 | 33.25 | 39.25 | 45.25 | 51.81 | 58.55 | Upgrade |
Other Long-Term Assets | 23.74 | 24.46 | 22.72 | 20.34 | 20.01 | 19.16 | Upgrade |
Total Assets | 393.58 | 242.32 | 396.85 | 234.31 | 311.04 | 387.04 | Upgrade |
Accrued Expenses | 49.19 | 34.75 | 32.45 | 10.67 | 9 | 8.78 | Upgrade |
Short-Term Debt | - | 10 | - | - | - | - | Upgrade |
Current Portion of Leases | 2.69 | 2.66 | 2.37 | 2.53 | 2.5 | 2.46 | Upgrade |
Current Unearned Revenue | - | - | - | - | - | 30.8 | Upgrade |
Other Current Liabilities | 68.49 | 13.36 | 12.64 | 12.43 | 15.45 | 43.84 | Upgrade |
Total Current Liabilities | 120.36 | 60.77 | 47.45 | 25.63 | 26.95 | 85.88 | Upgrade |
Long-Term Leases | 1.6 | 2.95 | 5.6 | - | 2.53 | 5.02 | Upgrade |
Long-Term Unearned Revenue | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 | 2.03 | Upgrade |
Total Liabilities | 124.72 | 66.47 | 55.81 | 28.39 | 32.24 | 92.93 | Upgrade |
Common Stock | 1,076 | 876.29 | 877.94 | 678.34 | 674.34 | 674.34 | Upgrade |
Additional Paid-In Capital | 916.25 | - | - | 830.76 | 830.5 | 830.5 | Upgrade |
Retained Earnings | -1,724 | -1,637 | -1,472 | -1,302 | -1,226 | -1,211 | Upgrade |
Comprehensive Income & Other | - | 936.25 | 935.48 | -1.19 | - | - | Upgrade |
Shareholders' Equity | 268.86 | 175.85 | 341.04 | 205.92 | 278.8 | 294.11 | Upgrade |
Total Liabilities & Equity | 393.58 | 242.32 | 396.85 | 234.31 | 311.04 | 387.04 | Upgrade |
Total Debt | 4.28 | 15.6 | 7.97 | 2.53 | 5.02 | 7.49 | Upgrade |
Net Cash (Debt) | 328.28 | 127.2 | 315.72 | 157.87 | 218.11 | 204.83 | Upgrade |
Net Cash Growth | 46.87% | -59.71% | 99.98% | -27.62% | 6.48% | -46.63% | Upgrade |
Net Cash Per Share | 3.73 | 1.45 | 4.31 | 2.34 | 3.23 | 3.04 | Upgrade |
Filing Date Shares Outstanding | 107.63 | 87.63 | 87.79 | 67.83 | 67.43 | 67.43 | Upgrade |
Total Common Shares Outstanding | 107.63 | 87.63 | 87.79 | 67.83 | 67.43 | 67.43 | Upgrade |
Working Capital | 214.34 | 117.28 | 277.48 | 136.34 | 201.73 | 130.78 | Upgrade |
Book Value Per Share | 2.50 | 2.01 | 3.88 | 3.04 | 4.13 | 4.36 | Upgrade |
Tangible Book Value | 238.61 | 142.6 | 301.79 | 160.67 | 226.99 | 235.57 | Upgrade |
Tangible Book Value Per Share | 2.22 | 1.63 | 3.44 | 2.37 | 3.37 | 3.49 | Upgrade |
Machinery | 8.99 | 10.55 | 10.25 | 10.25 | 10.25 | 10.02 | Upgrade |
Leasehold Improvements | - | 4.85 | 4.85 | 4.85 | 4.85 | 4.85 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.